Артериальная ригидность и эндотелиальная дисфункция у больных хронической обструктивной болезнью легких


https://doi.org/10.18093/0869-0189-2011-0-4-109-117

Полный текст:


Аннотация

Артериальная ригидность и эндотелиальная дисфункция у больных хронической обструктивной болезнью легких.


Об авторах

М. А. Макарова
ФГУ "НИИ пульмонологии" ФМБА России
Россия

научный сотрудник лаборатории интенсивной терапии и дыхательной недостаточности

105077, Россия, Москва, ул. 11-я Парковая, 32, корп. 4. Тел. / факс: (495) 465-52-64.



С. Н. Авдеев
ФГУ "НИИ пульмонологии" ФМБА России
Россия

д. м. н., проф., руководитель клинического отдела 

105077, Россия, Москва, ул. 11-я Парковая, 32, корп. 4. Тел. / факс: (495) 465-52-64.



Список литературы

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI / WHO workshop report. Last updated 2010. www.goldcopd.org

2. Celli B.R., MacNee W. ATS / ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS / ERS position paper. Eur. Respir. J. 2004; 23: 932–946.

3. Hansell A.L., Walk J.A., Soriano J.B. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur. Respir. J. 2003; 22: 809–814.

4. Janssens J.P., Herrmann F., MacGee W., Michel J.P. Cause of death in older patients with anatomo-pathological evidence of chronic bronchitis or emphysema: a case-control study based on autopsy findings. J. Am. Geriatr. Soc. 2001; 49: 571–576.

5. Rutten F.H., Moons K.G., Cramer M.J. et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross-sectional diagnostic study. Br. Med. J. 2005; 331: 1379.

6. Engstrom G., Wollmer P., Hedblad B. et al. Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from "men born in 1914", Malmo?, Sweden. Circulation 2001; 103: 3086–3091.

7. Huiart L., Ernst P., Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640–2646.

8. Rosengren A., Wilhelmsen L. Respiratory symptoms and long-term risk of death from cardiovascular disease, cancer and other causes in Swedish men. Int. J. Epidemiol. 1998; 27: 962–969.

9. Hole D.J., Watt G.C., Davey)Smith G. et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. Br. Med. J. 1996; 313: 711–775.

10. Sin D.D., Wu L., Anderson J.A. et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005; 60: 992–997.

11. Anthonisen N.R., Connett J.E., Enright P.L., Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the lung health study. Am. J. Respir. Crit. Care Med. 2002; 166: 333–339.

12. Anthonisen N.R., Connett J.E., Kiley J.P. et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. J.A.M.A. 1994; 272: 1497–1505.

13. Heindl S., Lehnert M., Criee C.P. et al. Marked sympathetic activation in patients with chronic respiratory failure. Am. J. Respir. Crit. Care Med. 2001; 164: 597–601.

14. Sin D.D., Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514–1519.

15. Ridker P.M., Buring J.E., Cook N.R., Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391–397.

16. 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens 2007; 25: 1105–1187.

17. Raine A.E.G., Margreiter R., Brunner P.P. et al. Report on management of renal failure in Europe, XXII 1991. Nephrol. Dial. Transplant. 1992; 7(Suppl. 2): 7–35.

18. Safar M.E., Levy B.I., Struijker)Boudier H. Current perspective on arterial stiffness and pulse pressure in hypertension and cardiovascular disease. Circulation 2003; 107: 2864–2869.

19. Finkelstein S.M., Collins V.R., Cohn J.N. Vascular compliance response to vasodilators by Fourier and pulse contour analysis. Hypertension 1988; 12: 380–387.

20. Laurent S., Cockcroft J., Van Bortel L. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 2006; 27: 2588–2605.

21. Dart A.M., Gatzka C.D., Kingwell B.A. et al. Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension 2006; 47: 785–790.

22. Hoeks A.P., Brands P.J., Smeets F.A., Reneman R.S. Assessment of the distensibility of superficial arteries. Ultrasound Med. Biol. 1990; 16: 121–128.

23. Laurent S., Caviezel B., Beck L. et al. Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension 1994; 23: 878–883.

24. Meinders J.M., Kornet L., Brands P.J., Hoeks A.P. Assessment of local pulse wave velocity in arteries using 2D distension waveforms. Ultrason Imag. 2001; 23: 199–215.

25. Мартынов А.И., Терновой С.К., Остроумова О.Д. и др. Особенности изменения растяжимости аорты у пожилых больных на фоне длительной терапии различными классами гипотензивных средств (по данным магнитно-резонансной томографии). Кардиология 2002; 5: 19–22.

26. Asmar R. Arterial stiffness and pulse wave velocity. Clinical applications. Paris. Elsevier; 1999.

27. Boutouyrie P., Pannier B. Measurement of arterial stiffness. In: Laurent S., Cockroft J. Central aortic blood pressure. 2008: 41–47.

28. Laurent S., Boutouyrie P., Asmar R. et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236–1241.

29. Shokawa T., Imazu M., Yamamoto M. et al. Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima study. Circ. J. 2005; 69: 259–264.

30. Mattace-Raso F.U., van der Cammen T.J., Hofman A. et al. Arterial stiffness and risk of corornary heart disease and stroke: the Rotterdam study. Circulation 2006; 113: 657–663.

31. Laurent S., Cockcroft J., Van Bortel L. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 2006; 27: 2588–2605.

32. DeLoach S.S., Townsend R.R. Vascular stiffness: Its measurements and significance for epidemiologic and outcome studies. Clin. J. Am. Soc. Nephrol. 2008; 3: 184–192.

33. Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов (3-й пересмотр). Кардиоваск. тер. и профилакт. 2008; 6: 1–32.

34. Asmar R., Benetos A., Topouchian J. et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485–490.

35. Amar J., Ruidavets J.B., Chamontin B. et al. Arterial stiffness and cardiovascular risk factors in a population-based study. J. Hypertens. 2001; 19: 381–387.

36. Недогода С.В., Лопатин Ю.М., Чаляби Т.А. и др. Изменение скорости распространения пульсовой волны при артериальной гипертензии. Южно-Рос. мед. журн. 2002; 3: 39–43.

37. Лопатин Ю.М., Илюхин О.В., Илюхина М.В. и др. Эластичность артерий и скорость пульсовой волны у больных с хронической сердечной недостаточностью различной этиологии. Сердеч. недостат. 2004; 5: 130–131.

38. Blacher J., Guerin A.P., Verbeke F.H. et al. Impact of aortic stiffnesson on survival in endstage renal disease. Circulation 1999; 99: 2434–2439.

39. Назарова О.А., Масленникова О.М., Фомин Ф.Ю. Оценка эластических свойств сосудов в клинике внутренних болезней. Иваново, 2007.

40. Yamashina A., Tomiyama H., Takeda K. et al. Validity, reproducibility and clinical significance of noninvasive brachialankle pulse wave velocity measurement. Hypertens. Res. 2002; 25: 359–364.

41. Imanishi R., Seto S., Toda G. et al. High brachial-ankle pulse wave velocity is an independent predictor of coronary artery disease in men. Hypertens. Res. 2004; 27: 71–78.

42. Shirai K., Utino J., Otsuka K. et al. A novel blood pressureindependent arterial wall stiffness parameter: cardio-ankle vascular index (CAVI). J. Atheroscler. Thromb. 2006; 13: 101–107.

43. Hayward C.S., Avolio A.P., O`Rourke M.F. et al. Arterial pulse wave velocity and heart rate. Hypertension 2002; 40: 8–9.

44. Millasseau S.C., Kelly R.P., Ritter J.M., Chowienczyk P.J. Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin. Sci. 2002; 103: 371–377.

45. Chowienczyk P.J., Kelly R.P., MacCallum H. et al. Photoplethysmographic assessment of pulse wave reflection. Blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J. Am. Coll. Cardiol. 1999; 34: 2007–2014.

46. Laucevicius A., Ryliskyte L., Petruioniene Z. et al. First experience with salbutomol – induced changes in the photoplethysmogaphic digital volume pulse. Semin. Cardiol. 2002; 8: 87–93.

47. Melson L.C., Millasseau S.C., Chowienczyk P.J. et al. Rapid non-invasive analysis of vascular function in pre-eclampsia Hypertens. Pregnancy J. 2000; 19 (Suppl. 1): 120–124.

48. Millasseau S.C., Guigui F.G., Kelly R.P. et al. Noninvasive assessment of the digital volume pulse. Comparison with the peripheral pressure pulse. Hypertension 2000; 36: 952–956.

49. Моисеева Н.М., Пономарев Ю.А., Сергеева М.В., Рогоза А.Н. Оценка показателей ригидности магистральных артерий по данным бифункционального суточного мониторирования АД и ЭКГ прибором BPLab. Артер. гипертензия 2007; 1: 1–5.

50. Современные методы оценки состояния сосудов у больных артериальной гипертонией: Пособие для практикующих врачей / Рогоза А.Н., Балахонова Т.В., Чихладзе Н.М. и др. М.: Атмосфера; 2008.

51. Гельцер Б.И., Бродская Т.А. Результаты исследования центрального артериального давления у больных с хронической обструктивной болезнью легких. Тер. арх. 2008; 3: 15–20.

52. Jatoi N.A., Mahmud A., Benett K., Feely J. Assessment of arterial stiffness in hypertension: comparison of oscillometric (Arteriograph), piezoelectronic (Complior) and tonometric (SphygmoCor) techniques. J. Hypertens. 2009; 27: 2186–2191.

53. Ring M., Eriksson M.J., Farahnak P. et al. Arterial stiffness evaluation by sphygmocor and arteriograph. Heart, Lung Circ. 2008; 17S: S1–S209.

54. Wilkinson I.B., MacCallum H., Cockcroft J.R., Webb D.J. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br. J. Clin. Pharmacol. 2002; 53: 189–192.

55. Wilkinson I.B. Nitric oxide regulates local artery distensibility in vivo. Circulation 2002; 105: 213–217.

56. Fitch R.M., Vergona R., Sullivan M.E., Wang Y.X. Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc. Res. 2001; 51: 351–358.

57. Kinlay S., Creager M.A., Fukumoto M. et al. Endotheliumderived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension 2001; 38: 1049–1053.

58. Cohn J.N. Vascular wall function as a risk marker for cardiovascular disease. J. Hypertens. 1999; 17 (Suppl. 5): 41–44.

59. Schretzenmayr A. Uber kreislaufregulatorische vorgange an den groben arterien bei muskelarbeit. Pflüg. Arch. Ges. Physiol. 1933; 232: 743–748.

60. Celermajer D.S., Sorensen K.E., Gooch V.M. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115.

61. Corretti M.C., Anderson T.J., Benjamin E.J. et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery A report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 2002; 39: 257–265.

62. Blann A.D., Tarberner D.A. A reliable marker of endothelial cell dysfunction: does it exist? Br. J. Haematol. 1995; 90: 244–248.

63. Naka K.K., Tweddel A.C., Doshi S.H. et al. Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function. Eur. Heart J. 2006; 27: 302–309.

64. Илюхина М.В., Илюхин О.В., Калганова Е.Л. и др. Скорость распространения пульсовой волны в оценке эндотелиальной дисфункции у больных с хронической сердечной недостаточностью ишемической этиологии. Сердеч. недостат. 2005; 6 (3): 16–18.

65. Sugawara J., Maeda S., Otsuki T. et al. Effects of nitric oxide synthase inhibitor on decrease in peripheral arterial stiffness with acute low-intensity aerobic exercise. Hypertension 2004; 44: 119–20.

66. Widlansky M.E., Gokce N., Keaney J.F., Vita J.A. The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol. 2003; 42: 1149–1160.

67. Laucevicius A., Petrulioniene Z., Ryliskyte L. et al. Vascular dysfunction and wall structural changes in the assessment of cardiovascular risk: are we ready for "more soft" arterial damage criteria? Semin. Cardiol. 2004; 10: 340–345.

68. Vittone F., Vessari D., Mozerro C. et al. Evaluation of endothelium- dependent and independent vasodilatation in peiferal microcirculatory bed by laser doppler floumetry: comparison with venous occlusion plethysmography. J. Hypertens 2003; 21: 345–354.

69. Басте З.А., Елисеева Л.Н., Хуако М.Х. и др. Диагностические возможности лазерной допплерографии в оценке эндотелиальной дисфункции при гипертонической болезни. Регионар. кровообращ. и микроцирк. 2005; 1 (13).

70. Небиеридзе Д.В. Клиническое значение дисфункции эндотелия при артериальной гипертонии. Consilium Medicum. Систем. гипертензии. Прил.: 2005; 7 (1): 31–38.

71. Deanfield J., Donald A., Ferri C. et al. Endothelial function and dysfunction. Part 1: Methodological issues for assessment in the different vascular beds: A statement by the Working group on Endothelin and Endothelial Factors of the European Society of Hypertension. J. Hypertens. 2005; 23: 7–17.

72. Кароли Н.А., Ребров П.А. Эндотелиальная дисфункция и ее клиническое значение у больных хронической обструктивной болезнью легких. Клин. мед. 2005; 9: 10–16.

73. Sabit R., Bolton C.E., Edwards P.H. et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007; 175: 1259–1265.

74. Boussuges A., Rossi P., Gouitaa M., Nussbaum E. Alterations in the peripheral circulation in COPD patients. Clin. Physiol. Funct. Imag. 2007; 27: 284–290.

75. McAllister D.A., Maclay J.D., Mills N.L. et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007; 176: 1208–1214.

76. Maclay J.D., McAllister D.A., Mills N.L. et al. Vascular dysfunction in chronic obstructive pulmonary disease 2009. Am. J. Respir. Crit. Care Med. 2009; 180: 513–520.

77. Zureik M., Benetos A, Neukirch C. et al. Reduced pulmonary function is associated with central arterial stiffness in men. Am. J. Respir. Crit. Care Med. 2001; 164: 2181–2185.

78. Кароли Н.А., Ребров А.П. Влияние курения на развитие эндотелиальной дисфункции у больных хронической обструктивной болезнью легких. Пульмонология 2004; 2: 70–75.

79. Бродская Т.А., Гельцер Б.И., Невзорова В.А. Артериальная ригидность и болезни органов дыхания (патофизиологические механизмы и клиническое значение). Владивосток: Дальнаука; 2008.

80. Barr R.G., Mesia-Vela S., John H.M. et al. Impaired flowmediated dilation is associated with low pulmonary function and emphysema in ex-smokers. The Emphysema and Cancer Action Project (EMCAP) study. Am. J. Respir. Crit. Care Med. 2007; 176: 1200–1207.

81. Luscher T.F., Noll G. The endothelium as a regulator of vascular tone and growth. In: The endothelium in cardiovascular disease: pathophysiology, clinical presentation, and pharmacotherapy. Berlin; 1995. 1–24.

82. Vivodtzev I., Minet C., Wuyam B. et al. Significant improvement in arterial stiffness after endurance training in patients with COPD. Chest 2010; 137: 585–592.

83. Sharma S., Dransfield M.T., Cockcroft J. et al. Severity of arterial stiffness clinically differentiates moderate COPD patients. Am. J. Respir. Crit. Care Med. 2011; 183: A2612.


Дополнительные файлы

Для цитирования: Макарова М.А., Авдеев С.Н. Артериальная ригидность и эндотелиальная дисфункция у больных хронической обструктивной болезнью легких.  Пульмонология. 2011;(4):109-117. https://doi.org/10.18093/0869-0189-2011-0-4-109-117

For citation: Makarova M.A., Avdeev S.N. Arterial wall stiffness and endothelial dysfunction in patients with chronic obstructive pulmonary disease. Russian Pulmonology. 2011;(4):109-117. (In Russ.) https://doi.org/10.18093/0869-0189-2011-0-4-109-117

Просмотров: 462

Обратные ссылки

  • Обратные ссылки не определены.


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)